Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients
The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.
Source: NYT Health - Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Crispr (DNA) Food and Drug Administration Vertex Pharmaceuticals Inc CRISPR Therapeutics Clinical Trials Genetic Engineering Drugs (Pharmaceuticals) Source Type: news
More News: Anemia | Clinical Trials | Food and Drug Administration (FDA) | Genetics | Health | Sickle Cell Anemia